CTMX icon

CytomX Therapeutics (CTMX)

NASDAQ

$5.36

-$0.14 (

-2.46%

)

1D
5D
1M
6M
1Y
5Y
Market closed

CTMX: $5.36 / ₿ 0.0001 BTC / 8229 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$5.50
$0.40 - $6.35
$908.17M
0.63
$5.39
$2,882,555.81
169.44M
17.85
$3.90 - $15.00
$5.29 - $5.44
Yes

What is CytomX Therapeutics (CTMX)?

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

The CytomX Therapeutics (CTMX) stock price has been falling

The CytomX Therapeutics, Inc. Common Stock (CTMX) stock price today is $5.36, reflecting a -2.46% move since the market opened. The company’s market capitalization stands at $908.17M, with a daily trading volume of $2.88M shares. For investors tracking price trends, CytomX Therapeutics, Inc. Common Stock stock has ranged between $5.29 and $5.44 today. The previous closing price was $5.50.

Get started with CytomX Therapeutics (CTMX)

Ready to get started? Follow the steps below, or read our guide on how to buy CytomX Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy CTMX

Search for CTMX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy CTMX.

CTMX FAQs

CTMX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

CTMX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, CytomX Therapeutics, Inc. Common Stock (CTMX) has traded between a low of $0.40 and a high of $6.35.

CTMX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in CytomX Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
CTMX icon
CTMX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy CytomX Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.